Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Castle Biosciences Raises FY2025 Sales Guidance from $310.000M-$320.000M to $327.000M-$335.000M vs $317.599M Est

Author: Benzinga Newsdesk | November 03, 2025 04:12pm
Castle Biosciences (NASDAQ:CSTL) raises FY2025 sales outlook from $310.000 million-$320.000 million to $327.000 million-$335.000 million vs $317.599 million estimate.

Posted In: CSTL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist